Cargando…
Medical Aspects of mTOR Inhibition in Kidney Transplantation
The advances in transplant immunosuppression have reduced substantially the incidence of kidney graft rejection. In recent years, the focus has moved from preventing rejection to preventing the long-term consequences of long-standing immunosuppression, including nephrotoxicity induced by calcineurin...
Autores principales: | Cuadrado-Payán, Elena, Diekmann, Fritz, Cucchiari, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322634/ https://www.ncbi.nlm.nih.gov/pubmed/35887051 http://dx.doi.org/10.3390/ijms23147707 |
Ejemplares similares
-
Physiopathological role of extracellular vesicles in alloimmunity and kidney transplantation and their use as biomarkers
por: Cuadrado-Payán, Elena, et al.
Publicado: (2023) -
Practical considerations for the use of mTOR inhibitors
por: Diekmann, Fritz, et al.
Publicado: (2015) -
Biological Aspects of mTOR in Leukemia
por: Mirabilii, Simone, et al.
Publicado: (2018) -
Cancer and mTOR inhibitors in kidney transplantation recipients
por: Kao, Chih-Chin, et al.
Publicado: (2018) -
Development of calciphylaxis in kidney transplant recipients with a functioning graft
por: Guillén-Olmos, Elena, et al.
Publicado: (2021)